English
|
Spanish
Supporting oncology professionals through education
Login
Register
The content on this site is intended for healthcare professionals only
Menu
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
News
Latest news
Sign up for news alerts
Submit your news
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Journal information
Journal home
Charges
Editorial board
Founding editors
Editor-in-chief
Contact us
Author information
Submit article
Author guidelines
Editorial policies
Copyright information
Why publish with us
Reviewer information
Reviewer guidelines
Memberships
Videos
Recent videos
Sign up
Explore
Bone
Brain & nervous system
Breast
Colorectal & gastro
Haematology oncology
Head & neck
Hepatobiliary pancreatic
Lung & pleura
Melanoma & skin
Neuroendocrine
Ovary & gynaecology
Paediatric
Prostate & urology
Sarcomas
Conferences
Latest conferences
Sign up for latest coverage
Submit your event
About
e
cancer
About
e
cancer
Our founders
Funding statement
Contact us
Home
News
Journal
Video
e
learning
Events
Conferences
About us
Keyword
Breast
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
+
-
Bone
Brain & nervous system
Haematology oncology
Hepatobiliary pancreatic
Paediatric
Neuroendocrine
Sarcomas
ECCO-ESMO Patient advocacy symposium conclusions
Share :
ECCO 15 - ESMO 34
20 - 24 Sep 2009
Please rate this video
The information in this video was of interest to me
The information in this video is likely to improve my clinical practice or research
I would recommend this video to my colleagues
Published:
3 Nov 2009
Views:
10383
Rating:
Save
Rate video
Sandra Craine - Chronic Myeloid Leukaemia Support Group, UK
Sandra Craine from the Chronic Myeloid Leukaemia Support Group, UK, discusses the conclusions of the patient advocacy symposium at ECCO 15- ESMO 34, Berlin , 2009.
Categories:
Haematology oncology
Psychosocial
Related Videos
TP53 mutations are linked to unfavourable prognosis in chronic lymphocytic...
Dr Consuelo Bertossi - University Hospital of Ulm, Ulm, Germany
27 Jun 2024
Isa-VCd induction in NDMM patients with severe renal impairment show no new...
Prof Evangelos Terpos - University of Athens, School of Medicine, Athens, Greece
26 Jun 2024
A patient-reported questionnnaire may eliminate the need for an ophthalmic exam...
Prof Evangelos Terpos - University of Athens, School of Medicine, Athens, Greece
26 Jun 2024
Novel CAR-T cell therapy shows promise against calreticulin mutant neoplasms
Dr Alexandros Rampotas - UCL Cancer Institute, London, United Kingdom
26 Jun 2024
EHA 2024: Multiple myeloma roundup
Dr Claudio Cerchione - IRCCS, Meldola, Italy
26 Jun 2024
ATRA-ATO regimen with idarubicin could become the new standard of care in high...
Dr Uwe Platzbecker - University Hospital Leipzig, Leipzig, Germany
25 Jun 2024
Belantamab mafodotin, pomalidomide and dexamethasone shows superior efficacy in...
Prof Meletios Dimopoulos - University of Athens, Athens, Greece
24 Jun 2024
CAR-T therapy and impact to cancer patient outcomes and experience of treatment
Mr Matthias Hellberg-Naegele - Cantonal Hospital St Gallen, St Gallen...
7 Nov 2023
Haemopathy burden in the National Cancer Center of Cambodia
Dr Vannarith Kao - Calmette Hospital, Phnom Penh, Cambodia
20 Mar 2023
More from
e
cancer